These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6092239)

  • 1. R-enantiomer of timolol: a potential selective ocular antihypertensive agent.
    Share NN; Lotti VJ; Gautheron P; Schmitt C; Gross DM; Hall RA; Stone CA
    Graefes Arch Clin Exp Ophthalmol; 1984; 221(5):234-8. PubMed ID: 6092239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular hypotension in the rabbit. Receptor mechanisms of pirbuterol and nylidrin.
    Mittag TW; Tormay A; Messenger M; Podos SM
    Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):163-9. PubMed ID: 2857689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenergic receptor subtypes in iris-ciliary body of rabbits.
    Schmitt CJ; Gross DM; Share NN
    Graefes Arch Clin Exp Ophthalmol; 1984; 221(4):167-70. PubMed ID: 6142847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ICI 118,551: an effective ocular hypotensive agent with selectivity for the ciliary process beta 2-adrenoceptor and with minimal cardiac side effects.
    Nathanson JA
    Br J Pharmacol; 1984 Nov; 83(3):821-9. PubMed ID: 6150744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo cAMP level in rabbit iris-ciliary body after topical epinephrine treatment.
    Liu JH; Gallar J
    Curr Eye Res; 1996 Oct; 15(10):1025-32. PubMed ID: 8921241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and intraocular pressure lowering effect of timolol preparations in rabbit eyes.
    Chiang CH; Ho JI; Chen JL
    J Ocul Pharmacol Ther; 1996; 12(4):471-80. PubMed ID: 8951683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental studies with timolol: a new ocular hypotensive agent (author's transl)].
    Vareilles P; Schmitt C; Lotti VJ; Le Douarec JC
    J Fr Ophtalmol; 1978 Dec; 1(12):717-21. PubMed ID: 155095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of D-timolol on intraocular pressure (IOP), beta blocking activity, and the dynamic changes of drug concentrations in aqueous humor.
    Zhao F; Ji XC; Zheng YZ
    J Ocul Pharmacol; 1989; 5(4):271-9. PubMed ID: 2576432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beta-adrenergic blocking agents and the treatment of glaucoma.
    Zimmerman TJ; Boger WP
    Surv Ophthalmol; 1979; 23(6):347-62. PubMed ID: 37605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological effects of topical timolol in the rabbit eye.
    Bartels SP; Roth HO; Jumblatt MM; Neufeld AH
    Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1189-97. PubMed ID: 6106643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-653,328: an ocular hypotensive agent with modest beta receptor blocking activity.
    Sugrue MF; Gautheron P; Grove J; Mallorga P; Viader MP; Baldwin JJ; Ponticello GS; Varga SL
    Invest Ophthalmol Vis Sci; 1988 May; 29(5):776-84. PubMed ID: 2896641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of D-timolol for the treatment of glaucoma and ocular hypertension.
    Chiou GC
    J Ocul Pharmacol; 1990; 6(1):67-74. PubMed ID: 2193994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological evaluation of a new timolol/pilocarpine formulation.
    Bucolo C; Spadaro A; Mangiafico S
    Ophthalmic Res; 1998; 30(2):101-6. PubMed ID: 9523288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical properties and in vivo assessment of timolol-loaded poly(D,L-lactide-co-glycolide) films for long-term intraocular pressure lowering effects.
    Huang SF; Chen JL; Yeh MK; Chiang CH
    J Ocul Pharmacol Ther; 2005 Dec; 21(6):445-53. PubMed ID: 16386086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of timolol and other adrenergic agents on intraocular pressure in the rabbit.
    Vareilles P; Silverstone D; Plazonnet B; Le Douarec JC; Sears ML; Stone CA
    Invest Ophthalmol Vis Sci; 1977 Nov; 16(11):987-96. PubMed ID: 21145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of topical natural ergot alkaloids on the intraocular pressure and aqueous humor dynamics in rabbits with alpha-chymotrypsin-induced ocular hypertension.
    Puras G; Santafé J; Segarra J; Garrido M; Melena J
    Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):322-8. PubMed ID: 11981648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular pharmacokinetic/pharmacodynamic modeling for multiple anti-glaucoma drugs.
    Sakanaka K; Kawazu K; Tomonari M; Kitahara T; Nakashima M; Nishida K; Nakamura J; Sasaki H; Higuchi S
    Biol Pharm Bull; 2008 Aug; 31(8):1590-5. PubMed ID: 18670094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory and clinical studies on the mechanism of action of timolol.
    Neufeld AH; Bartels SP; Liu JH
    Surv Ophthalmol; 1983 Dec; 28 Suppl():286-92. PubMed ID: 6320482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the mechanism of action of timolol and on the effects of suppression and redirection of aqueous flow on outflow facility.
    Kiland JA; Gabelt BT; Kaufman PL
    Exp Eye Res; 2004 Mar; 78(3):639-51. PubMed ID: 15106944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of the beta-blockers timolol and H 216/44 to ocular melanin.
    Abrahamsson T; Boström S; Bräutigam J; Lagerström PO; Regårdh CG; Vauqelin G
    Exp Eye Res; 1988 Oct; 47(4):565-77. PubMed ID: 2903066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.